News

Find News

Filter articles

Showing 71 to 80 of 2458 results

Amgen prevails against Sanofi and Regeneron

US26-02-2019

A jury has upheld two of Amgen’s patents for its cholesterol drug Repatha, rejecting a challenge brought by two competitors.

Merck to buy immunotherapy company for $300m

US26-02-2019

US-based Merck & Co has announced plans to acquire immunotherapy company Immune Design for $300 million, in a bid to strengthen its capabilities in vaccine development.

Roche to make $4.3bn gene therapy acquisition

US25-02-2019

Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal.

Cambridge University secures partial TM victory

UK25-02-2019

Cambridge University has secured a partial trademark victory against Cambridge NeuroTech, a neuroscience biotech company, before the UK Intellectual Property Office.

DLA Piper hires two patent litigators in New York

US25-02-2019

DLA Piper has hired two patent litigators as partners in the firm’s IP and technology practice.

ResMed and Fisher & Paykel settle patent disputes

New Zealand, US22-02-2019

American medical device maker ResMed and New Zealand-based competitor Fisher & Paykel have agreed to settle a global patent dispute over medical devices.

Indivior to launch generic after SCOTUS refuses petition

US22-02-2019

Indivior has launched a generic version of its opioid addiction drug Suboxone (buprenorphine and naloxone) Film, one day after the US Supreme Court denied its request to put a lower court’s ruling on hold.

Mexican Senate launches bill to modify patented drug prices

Mexico21-02-2019

The majority parliament group of the Mexican Senate has introduced a bill to modify the current scheme for setting maximum sale prices of patented medicines and supplies.

Federal Circuit disqualifies Katten from Mylan appeals

US21-02-2019

The US Court of Appeals for the Federal Circuit yesterday disqualified law firm Katten Muchin Rosenman from representing Mylan in three appeals before the court.

CPVO issues guidance on plant rights in no-deal Brexit

EU, UK20-02-2019

The EU’s Community Plants Variety Office has issued an information notice advising that owners of EU Community plant variety rights issued after January 29, 2019 will need to re-apply for equivalent UK rights in the event of a no-deal Brexit.

Showing 71 to 80 of 2458 results

LSIPR